Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.

@article{Mates2015SystemicTT,
  title={Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.},
  author={Mihaela Mates and Glenn G Fletcher and Orit C. Freedman and Andrew Eisen and Sonal Gandhi and M E Trudeau and Susan Dent},
  journal={Current oncology},
  year={2015},
  volume={22 Suppl 1},
  pages={S114-22}
}
BACKGROUND This systematic review addresses the question "What is the optimal targeted therapy for female patients with early-stage human epidermal growth factor receptor 2 (her2)-positive breast cancer?" METHODS The medline and embase databases were searched for the period January 2008 to May 2014. The Standards and Guidelines Evidence directory of… CONTINUE READING